Supports vaccine development from late preclinical stages to phase IIa clinical trials, including GMP production, immunomonitoring, and regulatory guidance.

Supports preclinical and early clinical development of small molecule drug candidates with access to screening, animal models, ADME profiling, toxicity studies, and clinical trial support.